Barbara Eifrig

506 citations

23 papers · 416 indexed · h-index 13

Impact in

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
- Hemophilia Treatment and Research
- Acute Myeloid Leukemia Research

Papers in ⓘ

Hematology 21
- Blood Coagulation and Thrombosis Mechanisms 10
- Platelet Disorders and Treatments 9
- Hemophilia Treatment and Research 7
- Blood groups and transfusion 2
Internal Medicine 5
- Venous Thromboembolism Diagnosis and Management 5

Co-authors: Florian Länger (13 shared papers)Carsten Bokemeyer (6 shared papers)Brigitte Spath (5 shared papers)Ali Amirkhosravi (5 shared papers)Katharina Holstein (4 shared papers)Martin Friedrich (2 shared papers)Felix K.‐H. Chun (2 shared papers)Jan Wierecky (1 shared paper)
Journals: Thrombosis and Haemostasis (3 papers)Blood (2 papers)Annals of Hematology (2 papers)Thrombosis Research (2 papers)Haemophilia (2 papers)
Partner nations: Germany United States Austria

In The Last Decade

Barbara Eifrig

23 papers receiving 406 citations

Peers

Countries citing papers authored by Barbara Eifrig

Since Specialization

Citations

This map shows the geographic impact of Barbara Eifrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Eifrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Eifrig more than expected).

Fields of papers citing papers by Barbara Eifrig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Eifrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Eifrig. The network helps show where Barbara Eifrig may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Eifrig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Eifrig Line = papers co-authored together Barbara Eifrig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation Annals of Hematology ·Florian Länger, Brigitte Spath, Katja Haubold, Katharina Holstein, Guy Marx, Jan Wierecky, Tim H. Brümmendorf, Judith Dierlamm, Carsten Bokemeyer, Barbara Eifrig	2008	79
2	Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer Thrombosis and Haemostasis ·Brigitte Spath, Martin Friedrich, Felix K.‐H. Chun, Guy Marx, Ali Amirkhosravi, John Francis, Carsten Bokemeyer, Barbara Eifrig, Katja Haubold, Michael Rink, Florian Länger	2009	59
3	Experimental metastasis and primary tumor growth in mice with hemophilia A Journal of Thrombosis and Haemostasis ·Florian Länger, Ali Amirkhosravi, Susan B. Ingersoll, Jamie M. Walker, Brigitte Spath, Barbara Eifrig, Carsten Bokemeyer, J L Francis	2006	42
4	Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers Thrombosis and Haemostasis ·Felix K.‐H. Chun, Ali Amirkhosravi, Martin Friedrich, Sven Leuenroth, Barbara Eifrig, Carsten Bokemeyer, John L. Francis, Florian Länger	2007	28
5	Efficacy, safety and tolerability of recombinant factor VIII (REFACTO^®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria Haemophilia ·H. Pöllmann, D. EXTERNEST, Arnold Ganser, Barbara Eifrig, W. Kreuz, H. Lenk, Ingrid Pabinger, W. Schramm, Tino F. Schwarz, R. Zimmermann, Nicholas Zavazava, Johannes Oldenburg, Robert Klamroth	2007	27
6	The impact of a specific aqua‐training for adult haemophilic patients – results of the WATERCISE study (WAT‐QoL) Haemophilia ·Sylvia von Mackensen, Barbara Eifrig, D. ZÄCH, J. KALNINS, A. WIELOCH, William W. Zeller	2012	22
7	Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses Transfusion and Apheresis Science ·K. Gutensohn, K. Geidel, N. Kroeger, Barbara Eifrig, N. Crespeigne, P. Kuehnl	2002	21
8	Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism Thrombosis Research ·Martin S. Weber, Frank Gerdsen, K. Gutensohn, Volker Schoder, Barbara Eifrig, D. K. Hossfeld	2002	20
9	Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases Annals of Hematology ·Florian Länger, Barbara Eifrig, Gerald R. Marx, Alexander Stork, S. Hegewisch-Becker, D. K. Hossfeld	2002	19
10	An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF Thrombosis and Haemostasis ·Ali Amirkhosravi, Sonja Loges, Todd Meyer, Barbara Eifrig, Dieter K. Hossfeld, Walter Fiedler, John Francis, Florian Länger	2004	18
11	Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation Bone Marrow Transplantation ·Michael Weber, Nicolaus Kröger, Florian Länger, Arne Hansen, Tatjana Zabelina, Barbara Eifrig, Dieter K. Hossfeld, A R Zander	2003	18
12	Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation Liver Transplantation ·Marc Willems, Martina Sterneck, Florian Länger, Roman Jung, Munif Haddad, Christian Hagel, Robert Kuetemeier, Barbara Eifrig, Dieter C. Bröering, Lutz Fischer, Xavier Rogiers	2003	14
13	Relationship between haemophilia and social status Thrombosis Research ·Katharina Holstein, Barbara Eifrig, Florian Länger	2014	12
14	Platelet Activation Markers in Patients with Venous Thromboembolism without Predisposing Factors Pathophysiology of Haemostasis and Thrombosis ·Frank Gerdsen, Martin S. Weber, Florian Länger, Barbara Eifrig, Edelgard Lindhoff‐Last	2005	8
15	Thrombophiliefaktoren als Auslöser retinaler Gefäßverschlüsse Der Ophthalmologe ·R. Ch. Lerche, Claudia Wilhelm, Barbara Eifrig, Guy Richard	2001	6
16	Biocompatibility of a new cell separator studied by flow cytometry: analyses of platelet antigens during apheresis and storage Transfusion ·K. Gutensohn, A. Alisch, N. Crespeigne, Barbara Eifrig, P. Kuehnl	1999	6
17	Inhibitor-Immunology-Study Hämostaseologie ·C. Wermes, Barbara Eifrig, Katharina Holstein, H. Pöllmann, Britta Siegmund, Christoph Bidlingmaier, Karin Kurnik, Antje Nimtz-Talaska, C. Niekrens, R. Eisert, Andreas Tiede, Chinedu Ulrich Ebenebe, M. Lakomek, Ludwig Hoy, Karl Welte, K.-W. Sykora, Ilse Wieland	2008	5
18	Role of Protein Disulfide Isomerase (PDI) In the Expression of Tissue Factor (TF) Procoagulant Activity on Apoptotic Myeloblasts Blood ·Brigitte Spath, Ali Amirkhosravi, Mónica Dávila, John L. Francis, Barbara Eifrig, Carsten Bokemeyer, Florian Länger	2010	4
19	Die perioperative Behandlung von Patienten mit hereditärem Angioödem (HAE) am Beispiel eines Jugendlichen mit Osteosynthese einer Oberschenkelfraktur AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie ·St. Eckert, Barbara Eifrig, T. Standl	2000	3
20	Tissue Factor (TF) Activation by Antithymocyte Globulin Is Inhibited by a Novel Monoclonal Antibody Specific for Reduced TF Mutated at the Allosteric Cys186-Cys209 Disulfide. Blood ·Florian Länger, Brigitte Spath, Francis Ayuk, Nicolaus Kroeger, Barbara Eifrig, Carsten Bokemeyer, Wolfram Ruf	2010	2

About Barbara Eifrig

Barbara Eifrig is a scholar working on Hematology, Internal Medicine, Genetics, Biochemistry and Immunology and Allergy, having authored 23 papers that have together received 416 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Blood disorders and treatments (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Internal Medicine (122 citations), Hematology (285 citations), Genetics (78 citations), Biochemistry (28 citations) and Critical Care and Intensive Care Medicine (15 citations). Barbara Eifrig has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Florian Länger, Carsten Bokemeyer, Brigitte Spath, Ali Amirkhosravi, Katharina Holstein, Martin Friedrich, Felix K.‐H. Chun, Jan Wierecky, Judith Dierlamm and Tim H. Brümmendorf. Their work appears in journals such as Thrombosis and Haemostasis, Blood, Annals of Hematology, Thrombosis Research and Haemophilia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact